MedPath

The efficacy of sucralfate in prevention of acute proctitis induced by radiotherapy in cancer patients

Phase 2
Conditions
acute radiation proctitis.
Radiation proctitis
Registration Number
IRCT201606042027N7
Lead Sponsor
Vice Chancellor for research of Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Inclusion Criteria: patients aged older than 18 years; need for pelvic radiation.

Exclusion Criteria

Evidence of active infection; evidence of other sources of hematochezia including colon cancer, inflammatory bowel disease, and hemorrhoids; anal incontinence; anorectal fistula; anorectal stenosis; previous rectal surgery; pregnancy or breast feeding; female of child-bearing age who doesn't use a secure contraception method; known allergy to any ingredients of ointments; concurrent use of antibiotics or steroids

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Developement of proctitis. Timepoint: before intervention, then weekly for six weeks after intervention. Method of measurement: based on clinical presentation.;Proctitis severity. Timepoint: before intervention, then weekly for six weeks after intervention. Method of measurement: based on Radiation Therapy Oncology Group (RTOG) criteria.
Secondary Outcome Measures
NameTimeMethod
The effect of paroctitis on the lifestyle with a scoring system described by Kennedy et al, 2001. Timepoint: before intervention, then weekly for six weeks after intervention. Method of measurement: based on questionnaire.;Quantitative CRP. Timepoint: before intervention, then weekly for six weeks after intervention. Method of measurement: based on patient's blood sample.;Patient's psycho-social state. Timepoint: before intervention, then weekly for six weeks after intervention. Method of measurement: based on Hospital Anxiety-Deprresion (HAD) scale.
© Copyright 2025. All Rights Reserved by MedPath